Search results
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 1 week agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer ...
Ligand Pharmaceuticals (LGND) to Release Quarterly Earnings on Tuesday
ETF DAILY NEWS· 2 days agoLigand Pharmaceuticals has set its FY 2024 guidance at 4.250-4.750 EPS and its FY24 guidance at $4.25 to $4.75 EPS.Parties interested in participating in the company’s conference ...